Mammalian monocarboxylate transporter 7 (MCT7/Slc16a6) is a novel facilitative taurine transporter

Monocarboxylate transporter 7 (MCT7) is an orphan transporter expressed in the liver, brain, and in several types of cancer cells. It has also been reported to be a survival factor in melanoma and breast cancers. However, this survival mechanism is not yet fully understood due to MCT7’s unidentified...

Full description

Bibliographic Details
Main Authors: Higuchi, K. (Author), Inoue, K. (Author), Kishimoto, H. (Author), Sugiyama, K. (Author), Tomabechi, R. (Author)
Format: Article
Language:English
Published: American Society for Biochemistry and Molecular Biology Inc. 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02735nam a2200373Ia 4500
001 10-1016-j-jbc-2022-101800
008 220425s2022 CNT 000 0 und d
020 |a 00219258 (ISSN) 
245 1 0 |a Mammalian monocarboxylate transporter 7 (MCT7/Slc16a6) is a novel facilitative taurine transporter 
260 0 |b American Society for Biochemistry and Molecular Biology Inc.  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1016/j.jbc.2022.101800 
520 3 |a Monocarboxylate transporter 7 (MCT7) is an orphan transporter expressed in the liver, brain, and in several types of cancer cells. It has also been reported to be a survival factor in melanoma and breast cancers. However, this survival mechanism is not yet fully understood due to MCT7’s unidentified substrate(s). Therefore, here we sought to identify MCT7 substrate(s) and characterize the transport mechanisms by analyzing amino acid transport in HEK293T cells and polarized Caco-2 cells. Analysis of amino acids revealed significant rapid reduction in taurine from cells transfected with enhanced green fluorescent protein-tagged MCT7. We found that taurine uptake and efflux by MCT7 was pH-independent and that the uptake was not saturated in the presence of taurine excess of 200 mM. Furthermore, we found that monocarboxylates and acidic amino acids inhibited MCT7-mediated taurine uptake. These results imply that MCT7 may be a low-affinity facilitative taurine transporter. We also found that MCT7 was localized at the basolateral membrane in polarized Caco-2 cells and that the induction of MCT7 expression in polarized Caco-2 cells enhanced taurine permeation. Finally, we demonstrated that interactions of MCT7 with ancillary proteins basigin/ CD147 and embigin/GP70 enhanced MCT7-mediated taurine transport. In summary, these findings reveal that taurine is a novel substrate of MCT7 and that MCT7-mediated taurine transport might contribute to the efflux of taurine from cells. © 2022 American Society for Biochemistry and Molecular Biology Inc.. All rights reserved. 
650 0 4 |a Amino acid transport 
650 0 4 |a Amino acids 
650 0 4 |a Amino-acids 
650 0 4 |a Breast Cancer 
650 0 4 |a Caco-2 cells 
650 0 4 |a Cancer cells 
650 0 4 |a Cells 
650 0 4 |a Cytology 
650 0 4 |a Diseases 
650 0 4 |a Mammals 
650 0 4 |a Melanoma cancer 
650 0 4 |a Proteins 
650 0 4 |a Rapid reduction 
650 0 4 |a Survival factor 
650 0 4 |a Survival mechanisms 
650 0 4 |a Transport mechanism 
700 1 |a Higuchi, K.  |e author 
700 1 |a Inoue, K.  |e author 
700 1 |a Kishimoto, H.  |e author 
700 1 |a Sugiyama, K.  |e author 
700 1 |a Tomabechi, R.  |e author 
773 |t Journal of Biological Chemistry